文献速递临床试验与 GCP真实世界研究与卫生经济

静脉性小腿溃疡初级保健疾病管理——Ulcus Cruris Care [UCC] 随机对照试验研究方案(DRKS00026126)

Primary care disease management for venous leg ulceration-study protocol for the Ulcus Cruris Care [UCC] randomized controlled trial (DRKS00026126).
PubMed 文献 · Trials · 2022-01-20

UCC试验为前瞻性整群随机对照多中心试验,拟招募50家全科诊所并按1:1随机分为干预组与对照组,每组纳入63例静脉性小腿溃疡患者。主要结局为溃疡愈合时间,次要结局包括溃疡数量与大小、复发、疼痛强度、健康相关生活质量、抑郁、患者满意度及治疗依从性,并附卫生经济学分析与过程评价。

要点

  • UCC试验评估Ulcus Cruris Care干预能否促进静脉性小腿溃疡愈合。
  • 干预为多组分措施,含全科医生与医疗助理在线培训及软件支持的病例管理。
  • 主要结局为溃疡愈合时间,每组拟纳入63例患者。

核心结论

  • UCC试验将评估Ulcus Cruris Care干预是否可能带来更快的伤口愈合、更高的健康相关生活质量和更低的医疗资源使用。
  • 若干预对所评估结局产生积极影响,可考虑在初级保健中全面实施。

研究设计与样本

  • UCC试验为前瞻性整群随机对照多中心试验,拟招募50家全科诊所并按1:1随机分为干预组或对照组。
  • 由参与的全科诊所招募静脉性小腿溃疡患者,每组拟纳入63例患者。
  • 干预为多组分措施,包括全科医生与医疗助理在线培训、标准化治疗推荐、患者电子学习与印刷信息、以及病例管理软件支持。

主要发现

  • 主要结局为溃疡愈合时间。
  • 次要结局包括溃疡数量与大小、复发、视觉模拟量表疼痛强度、EQ-5D-5L健康相关生活质量、PHQ-9抑郁、PACIC-5A患者满意度问卷及静脉性小腿溃疡治疗依从性。
  • 结局分析伴随卫生经济学分析与过程评价。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Venous leg ulcers (VLU) have a prevalence of 1-2% in developed countries, and affected patients are severely and long-term impaired in daily activities, work, and social participation. Evidence-based outpatient treatment based on compression therapy is frequently not implemented. The "Ulcus Cruris Care" project was established to develop a disease management concept to improve outpatient treatment for patients with VLU in German primary care. For this purpose, a multifaceted intervention was conceived consisting of an online training for general practitioners and medical assistants, standardized treatment recommendations, e-learning and print-based information for patients, and a software support for case management. The main aims of the Ulcus Cruris Care intervention are to promote standardized treatment according to current scientific knowledge, to facilitate case management for VLU patients exerted by medical assistants, and to support patient education and participation in the treatment process. The UCC trial was designed to evaluate the effectiveness of the Ulcus Cruris Care intervention. METHODS: The UCC trial is a prospective cluster-randomized controlled multicenter trial. Fifty GP practices are intended to be recruited and randomized 1:1 to intervention or control arm. Patients with venous leg ulcers will be recruited by participating GP practices, to include a total of 63 patients in each arm. The primary outcome is time to ulcer healing. Secondary outcomes comprise number and sizes of ulcers, recurrence, pain intensity according to the visual analog scale, health-related quality of life according to EQ-5D-5L, depressiveness according to Patient Health Questionnaire (PHQ-9), patient satisfaction according to the Patient Assessment of Chronic Illness Care (PACIC-5A) query, and adherence to VLU treatment. The outcome analysis of the UCC trial is accompanied by a health economic analysis and a process evaluation. DISCUSSION: The UCC trial will evaluate whether the Ulcus Cruris Care intervention may lead to faster wound healing, higher health-related quality of life, and lower use of medical resources. If the intervention turns out to have a positive impact on assessed outcomes, comprehensive implementation in primary care may be considered. TRIAL REGISTRATION: The trial protocol (version 1 as of July 19, 2021) has been registered in the German Clinical Trials Register on August 30, 2021 ( DRKS00026126 ).

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Senft JD, Fleischhauer T, Frasch J, et al. Primary care disease management for venous leg ulceration-study protocol for the Ulcus Cruris Care [UCC] randomized controlled trial (DRKS00026126). Trials. 2022. PMID: 35057840. doi:10.1186/s13063-021-05944-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。